|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 213/16 | |
| A61K 31/4406 |
| (11) | Number of the document | 2438045 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10724026.9 |
| Date of filing the European patent application | 2010-05-26 | |
| (97) | Date of publication of the European application | 2012-04-11 |
| (45) | Date of publication and mention of the grant of the patent | 2016-10-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2010/057273 |
| Date | 2010-05-26 |
| (87) | Number | WO 2010/139585 |
| Date | 2010-12-09 |
| (30) | Number | Date | Country code |
| 09007330 | 2009-06-03 | EP | |
| 306222 P | 2010-02-19 | US |
| (72) |
NAGEL, Norbert, DE
BERCHTOLD, Harald, DE
SCHUR, Michael, DE
HOERSTERMANN, Dirk, DE
|
| (73) |
Sanofi-Aventis Deutschland GmbH,
Brüningstra e 50, 65929 Frankfurt am Main,
DE
|
| (54) | CRYSTALLINE PHASES OF 2`-{[2-(4-METHOXY-PHENYL)-ACETYLAMINO]-METHYL}-BIPHENYL-2-CARBOXYLIC ACID (2-PYRIDIN-3-YL-ETHYL)-AMIDE |
| CRYSTALLINE PHASES OF 2`-{[2-(4-METHOXY-PHENYL)-ACETYLAMINO]-METHYL}-BIPHENYL-2-CARBOXYLIC ACID (2-PYRIDIN-3-YL-ETHYL)-AMIDE |